Eli Lilly and Company's top products based on revenue 2019-2020

Full access: To this and over 1 million additional datasets
Save Time: Downloads allow integration with your project
Valid data: Access to all sources and background information

Published by Matej Mikulic, Feb 23, 2021

In 2020, Trulicity was Eli Lilly's biggest revenue generator with about 5.1 billion U.S. dollars. The next highest revenue generating drug in 2019 was Humalog with about 2.6 billion U.S. dollars. Eli Lilly is a multi-national pharmaceutical company that is headquartered in Indianapolis, Indiana.

Eli Lilly Company

Eli Lilly was founded in 1876 in the United States. As of today, the company has almost 35 thousand employees globally. The company specializes in global health initiatives, diabetes care and a multitude of other products concerning human health. Eli Lilly currently markets products in over 120 countries globally. As of 2018, the company was among the top pharmaceutical companies based on both prescription sales and research and development spending.

Diabetes products by Eli Lilly

Eli Lilly is the manufacturer of several of the global top diabetic pharmaceutical products and treatments. As of 2017, Eli Lilly was the second top seller of anti-diabetic pharmaceuticals based on revenue. Globally, Trulicity, one of Eli Lilly’s top drugs used in the treatment of type II diabetes, is projected to be the top anti-diabetic pharmaceutical by the year 2024.